P90 ribosomal S6 kinases: A bona fide target for novel targeted anticancer therapies?-Reference-Cited by-同舟云学术

P90 ribosomal S6 kinases: A bona fide target for novel targeted anticancer therapies?

Published:2023-04 Issue: Volume:210 Page:115488
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Koutsougianni Fani,Alexopoulou Dimitra,Uvez Ayca,Lamprianidou Andromachi,Sereti Evangelia,Tsimplouli Chrisiida,Ilkay Armutak Elif,Dimas Konstantinos^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference197 articles.

1. Human rsk isoforms: cloning and characterization of tissue-specific expression;Moller;Am. J. Physiol.-Cell Physiol.,1994

2. MSK activation and physiological roles;Arthur;Front. Biosci.: J. Virt. Libr.,2008

3. The RSK family of kinases: emerging roles in cellular signalling;Anjum;Nat. Rev. Mol. Cell Biol.,2008

4. Regulation and function of the RSK family of protein kinases;Romeo;Biochem. J.,2012

5. The p90 RSK family members: common functions and isoform specificity;Lara;Cancer Res.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemical composition, antioxidant activity, and cytotoxicity of the aqueous extracts of Dracaena arborea and Bridelia ferruginea: In vitro and in silico studies;South African Journal of Botany;2024-10

2. Phytochemical composition, antioxidant and cytotoxicity of the aqueous extracts of Dracaena arborea andBridelia ferruginea: in vitro and in silico studies.;2024-04-23

3. Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study;Bioorganic Chemistry;2024-02

4. What should be the future direction of development in the field of prostate cancer with lung metastasis?;World Journal of Clinical Oncology;2023-10-24

5. Synthesis and anti‐tumor activity evaluation of 1H‐pyrrolo[2,3‐b]pyridine‐2‐carboxamide derivatives with phenyl sulfonamide groups as potent RSK2 inhibitors;Chemical Biology & Drug Design;2023-10-18